As of Dec 15
| 0.00 / 0.00%|
The 23 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 85.00, with a high estimate of 96.00 and a low estimate of 65.00. The median estimate represents a +12.48% increase from the last price of 75.57.
The current consensus among 31 polled investment analysts is to Buy stock in Gilead Sciences. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.